Novagali’s Product Portfolio
Fully integrated product development: from research to market authorization
Our pipeline includes products at various stage of development that address diseases of the three segments of the eye.
Pipeline
| Products | Pre - clinical | Phase 1 | Phase 2 | Phase 3 | Registration | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surface |
|||||||||||||
| Vekacia® Cyclosporine A VKC |
X | X | X | X | X | X | X | ||||||
| Cyclokat® Cyclosporine A MODERATE TO SEVERE DRY EYE |
X | X | X | X | X | X | X | ||||||
| Anterior Segment |
Catioprost® Latanoprost GLAUCOMA |
X | X | X | X | X | |||||||
| Posterior Segment |
Cortiject® Corticosteroid DIABETIC MACULAR EDEMA |
X | X | X | |||||||||